Cargando…

892. Risk Factors for Adverse Events in Children Receiving Outpatient Antibiotic Therapy

BACKGROUND: Outpatient parenteral antibiotic therapy (OPAT) can decrease the length of hospital stay but is associated with adverse events (AEs). The purpose of this study was to quantify and identify risk factors for OPAT-associated AEs in children. METHODS: This is a retrospective, single-center s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillon, Jessica, Townsley, Elizabeth, Jimenez-Truque, Natalia, Garguilo, Kathryn, Banerjee, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809040/ http://dx.doi.org/10.1093/ofid/ofz359.051

Ejemplares similares

358. Sociodemographic and clinical features of children and adolescents with SARS-CoV-2 infection in Nashville, Tennessee
por: Howard, Leigh, et al.
Publicado: (2020)

2239. Randomized Controlled Trial of a PROcalcitonin-Guided Antibiotic Treatment Algorithm Plus Antibiotic Stewardship the Pediatric Intensive Care Unit (ProPICU)
por: Katz, Sophie, et al.
Publicado: (2019)

1669. Impact of Required Durations of Therapy for Antibiotic Orders at the Time of Order Entry
por: Wright, Megan R, et al.
Publicado: (2023)

1803. Clinical Impact of Rapid Blood Culture Diagnostics Differs by Time of Day and Gram Stain Type: Lessons From Implementation of Verigene® Blood Culture Testing in a Children’s Hospital
por: Katz, Sophie, et al.
Publicado: (2018)

1654. Impact of a Daily Web-Based Educational Quiz on Appropriateness of Pediatric Outpatient Antibiotic Prescribing
por: Lehrer, Brittany J, et al.
Publicado: (2023)

1126. Variability in Antibiotic Use in Children’s Hospitals in the United States
por: Griffith, Hannah, et al.
Publicado: (2019)

1137. Variability of Antibiotic Use in Neonatal Intensive Care Units in the United States
por: Dantuluri, Keerti, et al.
Publicado: (2019)

1345. Impact of the COVID-19 Pandemic on Pediatric Ambulatory Antibiotic Use in an Academic Health System
por: Katz, Sophie E, et al.
Publicado: (2020)

1348. Indirect Standardization to Improve Comparison of Children’s Hospitals’ Antimicrobial Use
por: Wattier, Rachel, et al.
Publicado: (2020)

A qualitative assessment of nonclinical drivers of pediatric outpatient antibiotic prescribing: The importance of continuity
por: Spencer, Hillary J. J., et al.
Publicado: (2022)

235. In outpatient clinics serving Veterans, antibiotic prescriptions precede a minority of antibiotic-associated adverse events
por: Wilson, Brigid, et al.
Publicado: (2020)

1334. A Qualitative Assessment of Drivers of Antimicrobial Prescribing for Pediatric Patients in Diverse Ambulatory Settings
por: Spencer, Hillary, et al.
Publicado: (2020)

857. Impact of Rapid Antibiotic Susceptibility Testing for Gram Negative Bacteremia Varies by Pathogen Type and Resistance: A Secondary Analysis of the RAPIDS GN Trial
por: Banerjee, Ritu, et al.
Publicado: (2023)

892. Determination of the Unavailability of Alternative Antiretroviral Formulations
por: Murray, Milena M, et al.
Publicado: (2021)

The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study
por: Howard, Leigh M., et al.
Publicado: (2021)

1758. Retrospective cohort analysis of outcomes in patients receiving outpatient parenteral antibiotic therapy (OPAT)
por: Billmeyer, Kaylyn, et al.
Publicado: (2022)

Prospective Observational Study to Determine Kinetics of Procalcitonin in Hospitalized Children Receiving Antibiotic Therapy for Non-Critical Acute Bacterial Infections
por: Katz, Sophie E., et al.
Publicado: (2020)

1416. The Economic Burden of Adverse Events Requiring Acute Care Services from Outpatient Parenteral Antibiotic Therapy (OPAT) Treatment
por: Rodriguez, Mauricio, et al.
Publicado: (2022)

Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions
por: Banerjee, Ritu, et al.
Publicado: (2023)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

1793. Clinical Outcomes among Febrile Infants Before and After Implementation of BioFire® FilmArray® Panels
por: Crook, Jennifer, et al.
Publicado: (2019)

1374. Carbapenem-Resistant Enterobacterales Infection in Children: Clinical and Molecular Data from a Prospective Multicenter Cohort Study
por: Fisher, Matthew, et al.
Publicado: (2020)

Adverse Events Releated to Antibiotic Use in Patients with Myasthenia Gravis
por: Zeitler, Kristen, et al.
Publicado: (2017)

1243. Comparative Analysis of Antimicrobial-related Adverse Events in the Outpatient Treatment of Staphylococcal Infections
por: Smith, Bradley, et al.
Publicado: (2018)

351. Factors Predicting Readmission within 90 days in Patients Receiving Outpatient Parenteral Antibiotic Therapy
por: Smola, Kyle, et al.
Publicado: (2023)

1052. Do Healthcare Providers De-Escalate β-Lactam (BL) Antibiotic Therapy Based on Results of Antibiotic Susceptibility Testing (AST)? Analysis of Bloodstream Infections (BSI) Caused by Escherichia coli and Klebsiella pneumoniae From the Veterans Health Administration (VHA)
por: Viau, Roberto, et al.
Publicado: (2018)

779. PIDS Featured Oral Abstract: High Beta Lactam Exposure in Neonates with Bloodstream Infection Associated with Intestinal Dysbiosis and Enterococcus spp. Abundance in the Gut Microbiome
por: Hendricks, Hope, et al.
Publicado: (2022)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

688. Risk of Clostridioides difficile Infection and Antibiotic Associated Diarrhea in Patients Receiving Outpatient Parenteral Antimicrobial Therapy
por: Jaramillo, Mario, et al.
Publicado: (2023)

966 Risk factors for colonization or infection with multi-drug resistant Escherichia coli in children
por: Uzodi, Adaora, et al.
Publicado: (2014)

Rurality of Residence and Inappropriate Antibiotic Use for Acute Respiratory Infections Among Young Tennessee Children
por: Dantuluri, Keerti L, et al.
Publicado: (2020)

892. Epidemiology, clinical features, and outcomes of Rhinovirus/Enterovirus in older adults hospitalized with acute respiratory infections and those with CHF and COPD exacerbations
por: Ess, Gabby, et al.
Publicado: (2023)

$\overline{K}^{0*}$(892) and K$^{0*}$(892) production at low p$_{T}$ and the quark parton model
por: Fawcett, H, et al.
Publicado: (1990)

357. High Rate of Adverse Events in Patients Receiving Oral Antimicrobials Under a COpAT Monitoring Protocol
por: Sawey, Ciara, et al.
Publicado: (2023)

740. A Comparison of Process Outcomes Among Patients Receiving Outpatient Parenteral Antibiotic Therapy in Different Settings: A Quality Improvement Project
por: Brady, Daniel, et al.
Publicado: (2019)

892. Meningitis after Ventricular Shunt Operations: Multicenter Study to Identify Etiology, Incidence and Risk Factors
por: Giarola, Lucca G, et al.
Publicado: (2020)

745 Risk of Peripheral Blood Eosinophilia and Hypersensitivity Reactions among Patients Receiving Outpatient Parenteral Antibiotics
por: Blumenthal, Kimberly, et al.
Publicado: (2014)

2296. Hypoglycemia Risk with Antibiotics: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS)
por: Kennedy, Kaitlin E, et al.
Publicado: (2019)

2950. Guideline discordant antibiotic treatment in the Emergency Department is associated with increased adverse events and length of stay
por: Breeden, Maddy, et al.
Publicado: (2023)

Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures
por: Butler, Anne M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tmclvi9gu2l53j983ptbvtkmuh